NEW YORK STATE COMMON RETIREMENT FUND - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,000
-97.6%
616
-98.2%
0.00%
Q1 2022$41,000
-63.1%
34,216
+0.4%
0.00%
Q4 2021$111,000
-27.5%
34,077
-0.6%
0.00%
Q3 2021$153,000
-17.3%
34,280
+0.8%
0.00%
Q2 2021$185,000
-26.3%
34,009
+1.2%
0.00%
Q1 2021$251,000
-20.6%
33,600
+15.5%
0.00%
Q4 2020$316,000
-11.5%
29,100
-28.0%
0.00%
Q3 2020$357,000
-17.2%
40,4000.0%0.00%
-100.0%
Q2 2020$431,000
+131.7%
40,400
+29.1%
0.00%
Q1 2020$186,000
-13.5%
31,300
+0.6%
0.00%
Q4 2019$215,000
-41.3%
31,100
-11.9%
0.00%
Q3 2019$366,000
+11.9%
35,3000.0%0.00%
Q2 2019$327,000
+31.9%
35,300
+30.3%
0.00%
Q1 2019$248,000
+64.2%
27,1000.0%0.00%
Q4 2018$151,000
-53.3%
27,1000.0%0.00%
Q3 2018$323,000
+16.6%
27,1000.0%0.00%
Q2 2018$277,000
+59.2%
27,100
+102.2%
0.00%
Q1 2018$174,000
+33.8%
13,4000.0%0.00%
Q4 2017$130,000
-34.0%
13,4000.0%0.00%
Q3 2017$197,000
-8.8%
13,4000.0%0.00%
Q2 2017$216,000
+170.0%
13,400
+167.9%
0.00%
Q1 2017$80,000
+31.1%
5,001
+0.0%
0.00%
Q4 2016$61,0005,0000.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders